The Lieber Institute for Brain Development to use BullFrog AI platform


Artificial intelligence and clinical data analytics services company BullFrog AI, and the Lieber Institute for Brain Development, an independent, not-for-profit medical research institute working to accelerate efforts to find new cures for developmental brain disorders, have signed a joint collaboration to apply BullFrog AI’s artificial intelligence platform to analyze anti-psychotic drug responses.

Under the terms of the agreement, BullFrog AI will utilize their AI platform to analyze large multi-factorial clinical data sets from patients who received antipsychotic medication.

[Image courtesy: Lieber Institute for Brain Development]